ArticleFrontiers in psychiatry2026
A cross-sectional study on social functioning and its associated factors among patients with severe mental illness in Minhang District, Shanghai.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To examine the current status of social functioning and its associated factors among patients with severe mental illness (SMI) in Minhang District, Shanghai, and to provide evidence for community-based rehabilitation interventions. Methods: A district-wide population-based cross-sectional survey was conducted in 2022 among all registered patients with SMI in Minhang District, Shanghai. Social functioning, perceived social support, anxiety symptoms, and depressive symptoms were assessed using the Social Disability Screening Schedule (SDSS), the Perceived Social Support Scale (PSSS), the Generalized Anxiety Disorder 7-item scale (GAD-7), and the Patient Health Questionnaire 9-item scale (PHQ-9), respectively. Univariate comparisons were performed using t-tests and ANOVA, with Bonferroni correction for Results: A total of 3510 eligible patients were included. The prevalence of social dysfunction was 36.6%, with social interaction as the most severely affected domain. Depressive symptoms were more prevalent than anxiety symptoms, and 11.3% of patients had comorbid anxiety and depressive symptoms. After adjusting for age and gender, more severe depressive symptoms were independently and positively associated with social dysfunction ( Clinical significance: More severe depressive symptoms were associated with greater social dysfunction among patients with SMI, while higher social support was associated with better social functioning. Routine screening and timely intervention for depressive symptoms may be considered in community mental health management. Methodological innovation: This district-wide census using standardized clinical assessments provides a replicable model for regional mental health surveys in other large cities in China. Public health value: Integrating depressive symptom screening into routine follow-up may help improve the efficiency of regional mental health services and promote social functioning recovery among patients with SMI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.